Partial
Partially Aligned
Patient Risk:
Moderate
Summary
Mechanism and general muscle/liver adverse effect counseling are broadly consistent with the label sections provided, but multiple efficacy/statistics claims and several safety associations (diabetes, cognitive effects) are not supported by the supplied labeling text. Peripheral artery disease is also not reflected in the provided indication section.
Category Scores
Accurate Statements
Lipitor (atorvastatin) belongs to the class of medications known as statins.
12.2 Pharmacodynamics references atorvastatin as a statin ("LIPITOR, like other lipid-lowering therapies"; class language) and 5 WARNINGS AND PRECAUTIONS uses statin comparisons ("like other statins").
Lipitor works by inhibiting the production of cholesterol in the liver.
12.1 Mechanism of Action: HMG-CoA reductase inhibition and "cholesterol synthesis in the liver".
Lipitor lowers LDL levels in the blood by blocking the enzyme HMG-CoA reductase.
12.1 Mechanism of Action: "selective, competitive inhibitor of HMG-CoA reductase"; inhibition leads to lower plasma cholesterol/lipoprotein levels including LDL.
Common side effects of Lipitor include muscle pain.
5.1 Skeletal Muscle: myopathy includes "muscle aches or muscle weakness" and advises patients to report unexplained muscle pain/tenderness/weakness.
Common side effects of Lipitor include liver damage.
5.2 Liver Dysfunction: biochemical abnormalities of liver function and transaminase elevations; includes contraindication for active liver disease/unexplained persistent elevations (describes liver-related adverse effect profile).
Unsupported Statements
A study in JAMA found that Lipitor significantly reduced LDL levels in patients with high cholesterol, with a median reduction of 38%.
No JAMA study or 38% median LDL reduction figure is present in the provided label text sections.
A study in the New England Journal of Medicine found that Lipitor reduced the risk of major cardiovascular events by 22% compared to placebo.
No NEJM/placebo/22% major cardiovascular events statistic is present in the provided label text sections.
Lipitor reduced LDL levels by an average of 45% over a 12-week period in over 10,000 patients in a cited real-world evidence source.
No such 12-week/10,000-patient/45% real-world evidence figure is present in the provided label text sections.
Lipitor is associated with an increased risk of diabetes.
No diabetes risk association is present in the provided label text sections.
Lipitor has been linked to an increased risk of cognitive impairment and memory loss in some patients.
No cognitive impairment/memory loss association is present in the provided label text sections.
Contradictions
Important Omissions
For cardiovascular risk reduction claims, the label text provided specifies reductions in myocardial infarction, stroke, revascularization/angina, CHF hospitalization (and angina) depending on patient group; it does not mention peripheral artery disease in the provided section.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
Unsupported safety associations (diabetes; cognitive impairment/memory loss) and unsupported efficacy statistics could mislead assessment of risk/benefit relative to the provided labeling text; however, core mechanism and labeled muscle/liver warnings are directionally consistent.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Moderate |
Recommendation
Partially Aligned
Primary Issue
Multiple quantitative efficacy claims and safety associations are not supported by the provided FDA label text sections; additionally, peripheral artery disease is included despite not being reflected in the provided indication text.
Suggested Improvement
Limit statements to what is explicitly supported in the supplied label sections (e.g., HMG-CoA reductase mechanism; labeled cardiovascular risk reductions by specified outcomes; labeled muscle and liver adverse effects/warnings). Remove or qualify unsupported study statistics and safety associations not present in the provided label text.